D-甘露糖全球市場

預計到 2032 年，全球 D-甘露糖市場規模將達到 16 億美元。

全球D-甘露糖市場規模預計在2025年為13億美元，在2025年至2032年的分析期內將以3.0%的複合年成長率成長，到2032年達到16億美元。本報告分析的細分市場之一－「粉劑型」市場預計在分析期間結束時將達到9.228億美元，複合年成長率為2.3%。 「膠囊和片劑型」市場預計在整個分析期內將以3.9%的複合年成長率成長。

美國市場規模估計為 3.565 億美元，而中國市場預計將以 5.0% 的複合年成長率成長。

預計到2025年，美國D-甘露糖市場規模將達到3.565億美元。作為世界第二大經濟體，中國預計在2025年至2032年的分析期內將以5.0%的複合年成長率成長，到2032年市場規模將達到3.101億美元。其他值得關注的區域市場包括日本和加拿大，預計在分析期內將分別以1.4%和2.3%的複合年成長率成長。在歐洲，德國預計將以約1.9%的複合年成長率成長。

全球D-甘露糖市場－主要市場趨勢與促進因素概述

為什麼D-甘露糖作為一種保健品越來越受歡迎？

D-甘露糖是一種天然醣類，在健康照護市場，尤其是作為尿道感染（UTI）的輔助治療產品，越來越受歡迎。與可能引起副作用和抗藥性的抗生素不同，D-甘露糖是一種更安全的替代療法，其作用機制是阻止細菌附著在泌尿道壁上。人們對天然療法和處方箋療法益處的認知不斷提高，推動了D-甘露糖在注重健康的消費者中的普及。它常被推薦為預防措施，尤其適用於反覆發生泌尿道感染的患者。隨著人們對天然功能性保健品的偏好日益成長，D-甘露糖正成為膳食補充品市場不可或缺的一部分。

科學研究如何支持D-甘露糖市場的成長？

D-甘露糖在預防尿道感染（ UTI）方面的科學有效性已得到證實，這極大地促進了其市場擴張。臨床研究表明，D-甘露糖能夠顯著降低復發性尿道感染的發生率，且不會產生長期使用抗生素帶來的副作用。這些發現促使醫療保健專業人員和自然療法醫生推薦D-甘露糖作為維護泌尿道健康的預防和輔助性治療。此外，隨著研究探索其其他益處，例如改善腸道健康和增強整體免疫功能，其應用範圍正從泌尿系統護理擴展到其他領域。這些科學依據不僅增強了消費者的信心，也推動了D-甘露糖產品（包括粉劑、膠囊和飲料）研發的投資和創新。

D-甘露糖產品在哪些地區使用和銷售？

D-甘露糖產品主要透過保健食品店、藥局和專門銷售膳食補充劑的線上零售平台銷售。電子商務的便利性使消費者能夠輕鬆購買D-甘露糖產品，從而促進了其廣泛普及和使用。除了單獨的補充劑外，D-甘露糖還被添加到支持泌尿器官系統健康的複合產品中，例如蔓越莓補充劑和益生菌。這種多功能方案受到尋求全面健康解決方案的消費者的青睞。此外，專注於自然療法和女性健康的醫療保健專業人員和診所也擴大推薦和提供D-甘露糖，進一步擴大了其在醫療保健領域的應用。需求成長不僅限於已開發市場；在新興經濟體，隨著人們對自然療法和預防醫學的認知不斷提高，D-甘露糖的採用率也不斷上升。

哪些因素推動了D-甘露糖市場的成長？

D-甘露糖市場的成長受到多種因素的驅動，包括意識提升以及科學研究對其功效的支持。自我護理和預防性健康管理的趨勢促使消費者尋求非藥物替代方案，從而推動了D-甘露糖作為可靠有效選擇的銷售。電子商務平台的興起使這些產品更容易取得，並惠及全球消費者。此外，女性健康日益受到關注，以及對復發性尿道感染（UTI）解決方案的重視，也促進了對D-甘露糖的需求。產品配方創新，例如將D-甘露糖與益生菌和其他天然成分相結合，也透過吸引注重健康、尋求全面、多功能補充劑的消費者，為市場成長做出了貢獻。

部分：

劑型（粉末、膠囊/錠劑）、分銷管道（B2B分銷管道、B2C分銷管道）、應用領域（機能性食品、營養補充劑、藥品、動物飼料、其他應用）

大公司

• Atrium Innovations, Inc.
• Biotech Pharmacal, Inc.
• Dow, Inc.
• DuPont de Nemours, Inc.
• Hanseler AG
• Jarrow Formulas, Inc.
• Kyowa Kirin Co., Ltd.
• Now Health Group, Inc.
• NutriScience Innovations, LLC
• Pfanstiehl, Inc.

基於領域專家的觀點——融合了來自工業界、商界和學術界專家的觀點，並增加了超越傳統已發表研究的背景。

我們捕捉早期市場訊號——追蹤專家對話、公司趨勢和市場相關討論中出現的變化，而這些變化尚未完全反映在傳統的二級研究中。

我們利用廣泛且檢驗的資訊基礎設施，整合了來自會議、主題演講、專題研討會、部落格、公司資訊披露、年度報告、機構出版物和其他檢驗資訊來源的見解。

我們將訊號與策略市場方向連結起來—整合這些觀點，以確定市場走向、推動市場發展的因素以及哪些趨勢可能對您的策略最為重要。

我們提供詳細的企業資料——不僅是市場層級的分析，而且是對參與和促成競爭環境形成的公司進行徹底的考察。

深入剖析關鍵區域的市佔率－單一的全球市佔率數據往往難以提供全貌。不同區域的競爭格局可能有顯著差異。在分析需求時，Market Glass 的報告會根據各市場的結構和趨勢調整分析的詳細程度，深入剖析關鍵區域的市場佔有率。

目錄

第1章：調查方法

第2章執行摘要

• 市場概覽
• 大公司
• 市場趨勢和促進因素
• 全球市場展望

第3章 市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 亞太其他地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東國家
• 非洲

第4章 競賽

Global D-Mannose Market to Reach US$1.6 Billion by 2032

The global market for D-Mannose estimated at US$1.3 Billion in the year 2025, is expected to reach US$1.6 Billion by 2032, growing at a CAGR of 3.0% over the analysis period 2025-2032. Powder Form, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$922.8 Million by the end of the analysis period. Growth in the Capsules & Tablets Form segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$356.5 Million While China is Forecast to Grow at 5.0% CAGR

The D-Mannose market in the U.S. is estimated at US$356.5 Million in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$310.1 Million by the year 2032 trailing a CAGR of 5.0% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global D-Mannose Market - Key Trends & Drivers Summarized

Why Is D-Mannose Gaining Popularity as a Health Supplement?

D-Mannose, a naturally occurring sugar, has seen rising demand in the health and wellness market, particularly as a supplement for managing urinary tract infections (UTIs). Unlike antibiotics, which can have side effects and lead to antibiotic resistance, D-Mannose is a safer alternative that works by preventing bacteria from adhering to the walls of the urinary tract. The growing awareness of the benefits of natural and non-prescription treatments has contributed to the popularity of D-Mannose among health-conscious consumers. It is frequently recommended as a preventive solution, especially for individuals with recurrent UTIs. With an increasing preference for natural and functional health products, D-Mannose is becoming a staple in the dietary supplement market.

How Are Scientific Studies Supporting the Growth of the D-Mannose Market?

The scientific validation of D-Mannose’s efficacy in preventing UTIs has played a significant role in the expansion of its market. Clinical studies have demonstrated that D-Mannose can significantly reduce the incidence of recurrent UTIs without the adverse effects associated with long-term antibiotic use. These findings have led healthcare professionals and naturopaths to recommend D-Mannose as a preventive measure or supplementary treatment for urinary health. Furthermore, research exploring its additional benefits, such as improving gut health and supporting overall immune function, is expanding its application scope beyond urinary care. This scientific backing not only boosts consumer confidence but also attracts investment and innovation in the development of D-Mannose products, including powders, capsules, and beverages.

Where Are D-Mannose Products Being Utilized and Sold?

D-Mannose products are primarily sold through health stores, pharmacies, and online retail platforms specializing in dietary supplements. The convenience of e-commerce has allowed consumers to access D-Mannose products easily, contributing to its widespread availability and use. Apart from standalone supplements, D-Mannose is also incorporated into combination products that address urinary health, such as cranberry supplements and probiotics. This multifunctional approach appeals to consumers seeking comprehensive wellness solutions. Additionally, healthcare professionals and clinics focusing on natural medicine and women’s health often recommend and distribute D-Mannose, increasing its penetration into medical and wellness practices. The growth in demand is not limited to developed markets; emerging economies are also witnessing increased adoption as awareness of natural and preventive healthcare options rises.

What Factors Are Driving the Growth of the D-Mannose Market?

The growth in the D-Mannose market is driven by several factors, including the increasing preference for natural health products, rising consumer awareness about urinary health, and scientific research validating its benefits. The trend towards self-care and preventive health management has led consumers to seek non-pharmaceutical alternatives, boosting D-Mannose sales as a trusted and effective option. The rise of e-commerce platforms has further facilitated access to these products, making them available to a global audience. In addition, the focus on women’s health and the emphasis on solutions for recurrent UTIs have propelled the demand for D-Mannose. Innovation in product formulations, such as incorporating D-Mannose with probiotics or other natural ingredients, also contributes to market growth by appealing to health-conscious consumers seeking holistic and multifunctional supplements.

SCOPE OF STUDY:

The report analyzes the D-Mannose market by the following Segments, and Geographic Regions/Countries:

Segments:

Form (Powder Form, Capsules & Tablets Form); Distribution Channel (B2B Distribution Channel, B2C Distribution Channel); End-Use (Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

• Atrium Innovations, Inc.
• Biotech Pharmacal, Inc.
• Dow, Inc.
• DuPont de Nemours, Inc.
• Hanseler AG
• Jarrow Formulas, Inc.
• Kyowa Kirin Co., Ltd.
• Now Health Group, Inc.
• NutriScience Innovations, LLC
• Pfanstiehl, Inc.

WHAT SETS THIS REPORT APART FROM OTHERS?

Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.

Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.

Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.

Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.

Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.

Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • D-Mannose - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for 46 Players Worldwide in 2026 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Urinary Tract Infections (UTIs) Boosting Demand for D-Mannose
  • Growing Consumer Preference for Natural and Plant-Based Supplements
  • Increasing Awareness About the Health Benefits of D-Mannose in Preventive Healthcare
  • Development of D-Mannose-Based Products for Enhanced Bioavailability
  • Expansion of the Functional Foods and Dietary Supplements Market Supporting Growth
  • Increasing Focus on Women's Health and UTI Prevention Driving Product Adoption
  • Rising Popularity of D-Mannose as an Alternative to Antibiotics
  • Growth in Online Retail Channels Expanding Accessibility of D-Mannose Supplements
  • Demand for Organic and Non-GMO Supplements Fueling Market Expansion
  • Expansion of Clinical Studies Validating the Efficacy of D-Mannose in UTI Treatment
  • Innovations in Product Formulations Such as Capsules, Powders, and Gummies
  • Increase in Direct-to-Consumer Marketing Strategies Expanding Market Reach
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World D-Mannose Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
  • TABLE 2: World Recent Past, Current & Future Analysis for D-Mannose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 3: World Historic Review for D-Mannose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 4: World 13-Year Perspective for D-Mannose by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • TABLE 5: World Recent Past, Current & Future Analysis for Powder Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 6: World Historic Review for Powder Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 7: World 13-Year Perspective for Powder Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 8: World Recent Past, Current & Future Analysis for Capsules & Tablets Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 9: World Historic Review for Capsules & Tablets Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 10: World 13-Year Perspective for Capsules & Tablets Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 11: World Recent Past, Current & Future Analysis for B2B Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 12: World Historic Review for B2B Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 13: World 13-Year Perspective for B2B Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 14: World Recent Past, Current & Future Analysis for B2C Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 15: World Historic Review for B2C Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 16: World 13-Year Perspective for B2C Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 17: World Recent Past, Current & Future Analysis for Functional Food End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 18: World Historic Review for Functional Food End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 19: World 13-Year Perspective for Functional Food End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 20: World Recent Past, Current & Future Analysis for Dietary Supplements End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 21: World Historic Review for Dietary Supplements End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 22: World 13-Year Perspective for Dietary Supplements End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 23: World Recent Past, Current & Future Analysis for Pharmaceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 24: World Historic Review for Pharmaceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 25: World 13-Year Perspective for Pharmaceuticals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 26: World Recent Past, Current & Future Analysis for Animal Feed End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 27: World Historic Review for Animal Feed End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 28: World 13-Year Perspective for Animal Feed End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 31: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032

III. MARKET ANALYSIS

• UNITED STATES
  • D-Mannose Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 33: USA Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 34: USA 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 35: USA Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 36: USA Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 37: USA 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 38: USA Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 39: USA Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 40: USA 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 42: Canada Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 43: Canada 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 44: Canada Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 45: Canada Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 46: Canada 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 47: Canada Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 48: Canada Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 49: Canada 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• JAPAN
  • D-Mannose Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 51: Japan Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 52: Japan 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 53: Japan Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 54: Japan Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 55: Japan 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 56: Japan Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 57: Japan Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 58: Japan 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• CHINA
  • D-Mannose Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 60: China Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 61: China 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 62: China Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 63: China Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 64: China 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 65: China Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 66: China Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 67: China 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• EUROPE
  • D-Mannose Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for D-Mannose by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 69: Europe Historic Review for D-Mannose by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 70: Europe 13-Year Perspective for D-Mannose by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
  • TABLE 71: Europe Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 72: Europe Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 73: Europe 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 74: Europe Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 75: Europe Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 76: Europe 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 77: Europe Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 78: Europe Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 79: Europe 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• FRANCE
  • D-Mannose Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 81: France Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 82: France 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 83: France Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 84: France Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 85: France 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 86: France Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 87: France Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 88: France 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• GERMANY
  • D-Mannose Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 90: Germany Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 91: Germany 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 92: Germany Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 93: Germany Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 94: Germany 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 95: Germany Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 96: Germany Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 97: Germany 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 99: Italy Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 100: Italy 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 101: Italy Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 102: Italy Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 103: Italy 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 104: Italy Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 105: Italy Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 106: Italy 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• UNITED KINGDOM
  • D-Mannose Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 108: UK Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 109: UK 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 110: UK Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 111: UK Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 112: UK 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 113: UK Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 114: UK Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 115: UK 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 117: Spain Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 118: Spain 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 119: Spain Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 120: Spain Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 121: Spain 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 122: Spain Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 123: Spain Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 124: Spain 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 126: Russia Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 127: Russia 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 128: Russia Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 129: Russia Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 130: Russia 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 131: Russia Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 132: Russia Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 133: Russia 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 136: Rest of Europe 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 139: Rest of Europe 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 142: Rest of Europe 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• ASIA-PACIFIC
  • D-Mannose Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for D-Mannose by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for D-Mannose by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 145: Asia-Pacific 13-Year Perspective for D-Mannose by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 148: Asia-Pacific 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 151: Asia-Pacific 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 154: Asia-Pacific 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• AUSTRALIA
  • D-Mannose Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 156: Australia Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 157: Australia 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 158: Australia Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 159: Australia Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 160: Australia 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 161: Australia Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 162: Australia Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 163: Australia 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• INDIA
  • D-Mannose Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 165: India Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 166: India 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 167: India Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 168: India Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 169: India 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 170: India Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 171: India Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 172: India 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 174: South Korea Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 175: South Korea 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 177: South Korea Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 178: South Korea 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 180: South Korea Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 181: South Korea 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• LATIN AMERICA
  • D-Mannose Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for D-Mannose by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 192: Latin America Historic Review for D-Mannose by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 193: Latin America 13-Year Perspective for D-Mannose by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 195: Latin America Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 196: Latin America 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 198: Latin America Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 199: Latin America 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 201: Latin America Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 202: Latin America 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 204: Argentina Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 205: Argentina 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 207: Argentina Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 208: Argentina 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 210: Argentina Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 211: Argentina 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 213: Brazil Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 214: Brazil 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 216: Brazil Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 217: Brazil 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 219: Brazil Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 220: Brazil 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 222: Mexico Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 223: Mexico 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 225: Mexico Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 226: Mexico 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 228: Mexico Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 229: Mexico 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 232: Rest of Latin America 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 235: Rest of Latin America 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 238: Rest of Latin America 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• MIDDLE EAST
  • D-Mannose Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for D-Mannose by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 240: Middle East Historic Review for D-Mannose by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 241: Middle East 13-Year Perspective for D-Mannose by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 243: Middle East Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 244: Middle East 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 246: Middle East Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 247: Middle East 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 249: Middle East Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 250: Middle East 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 252: Iran Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 253: Iran 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 254: Iran Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 255: Iran Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 256: Iran 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 257: Iran Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 258: Iran Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 259: Iran 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 261: Israel Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 262: Israel 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 263: Israel Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 264: Israel Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 265: Israel 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 266: Israel Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 267: Israel Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 268: Israel 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 271: Saudi Arabia 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 274: Saudi Arabia 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 277: Saudi Arabia 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 279: UAE Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 280: UAE 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 281: UAE Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 282: UAE Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 283: UAE 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 284: UAE Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 285: UAE Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 286: UAE 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 289: Rest of Middle East 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 292: Rest of Middle East 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 295: Rest of Middle East 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• AFRICA
  • D-Mannose Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for D-Mannose by Form - Powder Form and Capsules & Tablets Form - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 297: Africa Historic Review for D-Mannose by Form - Powder Form and Capsules & Tablets Form Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 298: Africa 13-Year Perspective for D-Mannose by Form - Percentage Breakdown of Value Sales for Powder Form and Capsules & Tablets Form for the Years 2020, 2026 & 2032
  • TABLE 299: Africa Recent Past, Current & Future Analysis for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 300: Africa Historic Review for D-Mannose by Distribution Channel - B2B Distribution Channel and B2C Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 301: Africa 13-Year Perspective for D-Mannose by Distribution Channel - Percentage Breakdown of Value Sales for B2B Distribution Channel and B2C Distribution Channel for the Years 2020, 2026 & 2032
  • TABLE 302: Africa Recent Past, Current & Future Analysis for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 303: Africa Historic Review for D-Mannose by End-Use - Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 304: Africa 13-Year Perspective for D-Mannose by End-Use - Percentage Breakdown of Value Sales for Functional Food End-Use, Dietary Supplements End-Use, Pharmaceuticals End-Use, Animal Feed End-Use and Other End-Uses for the Years 2020, 2026 & 2032

IV. COMPETITION